Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malaria, Plasmodium Falciparum”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00519467
What this trial is testing

Safety and Efficacy Dose of Artesunate Used in Combination With LAPDAP Treatment of Uncomplicated Falciparum Malaria

Who this might be right for
Malaria
GlaxoSmithKline 120
Not applicableStudy completedNCT03217851
What this trial is testing

Prevalence Survey of Antimalarial Drug Resistance Markers

Who this might be right for
Malaria
University of Oxford 4,000
Not applicableStudy completedNCT00126906
What this trial is testing

Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: Malawi

Who this might be right for
Malaria, FalciparumHIV Infections
Centers for Disease Control and Prevention 700
Testing effectiveness (Phase 2)Study completedNCT01341704
What this trial is testing

Proof-of-Concept Study of MSP3-LSP Vaccine to Protect Against Malaria in Africa

Who this might be right for
Malaria
Vac4All 800
Large-scale testing (Phase 3)Study completedNCT00158548
What this trial is testing

ACT With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in Pakistan

Who this might be right for
MalariaFalciparum MalariaVivax Malaria
London School of Hygiene and Tropical Medicine 650
Large-scale testing (Phase 3)Study completedNCT02974348
What this trial is testing

Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa

Who this might be right for
Drug Resistant Malaria Due to Plasmodium Falciparum
University of Bamenda 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT06549257
What this trial is testing

Assessing the Safety, Immunogenicity and Ex-vivo Efficacy of Two Candidate Malaria Transmission Blocking Vaccines, Pfs25-IMX313 and Pfs45/48 Administered Alone and in Combination, in Matrix-M Adjuvant

Who this might be right for
Plasmodium Falciparum Malaria
University of Oxford 56
Early research (Phase 1)Active Not RecruitingNCT06320535
What this trial is testing

Assess an Escalating Dose, Multi-prime Vaccination Schedule of R21/Matrix-M™

Who this might be right for
Malaria,Falciparum
University of Oxford 36
Post-approval studies (Phase 4)Study completedNCT00425763
What this trial is testing

Efficacy of Amodiaquine-artesunate in Children Aged 6-59 Months With Uncomplicated P. Falciparum Malaria

Who this might be right for
Malaria
Centers for Disease Control and Prevention 110
Not applicableLooking for participantsNCT05711485
What this trial is testing

Platelet-Directed Whole Blood Transfusion Strategy for Malaria

Who this might be right for
Severe MalariaThrombocytopenia
Johns Hopkins Bloomberg School of Public Health 132
Not applicableStudy completedNCT04422015
What this trial is testing

Biological Mechanisms in Afebrile P. Falciparum Malaria

Who this might be right for
Falciparum Malaria
Alfredo Mayor 475
Early research (Phase 1)Study completedNCT00744133
What this trial is testing

Malaria Challenge With NF54 Strain

Who this might be right for
Plasmodium Falciparum Infection
National Institute of Allergy and Infectious Diseases (NIAID) 37
Large-scale testing (Phase 3)Study completedNCT03939104
What this trial is testing

A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combinations of 2 Anti-malarial Drugs (Asia)

Who this might be right for
Plasmodium Falciparum Malaria (Uncomplicated)
University of Oxford 103
Testing effectiveness (Phase 2)Study completedNCT02851108
What this trial is testing

Methylene Blue Against Falciparum Malaria in Burkina Faso

Who this might be right for
Malaria, Falciparum
Heidelberg University 100
Testing effectiveness (Phase 2)Looking for participantsNCT05478720
What this trial is testing

DON in Pediatric Cerebral Malaria

Who this might be right for
Malaria, Cerebral
Douglas Postels, MD, MS 152
Testing effectiveness (Phase 2)Study completedNCT04329104
What this trial is testing

Safety and Efficacy of CIS43LS Anti-malaria mAb in Mali

Who this might be right for
Plasmodium Falciparum InfectionMalaria
National Institute of Allergy and Infectious Diseases (NIAID) 348
Not applicableStudy completedNCT01829737
What this trial is testing

Malaria Transmission Studies in Mali

Who this might be right for
Malaria, Falciparum
National Institute of Allergy and Infectious Diseases (NIAID) 534
Early research (Phase 1)WithdrawnNCT07124156
What this trial is testing

A Challenge Study to Assess the Blood-stage Efficacy of Full-length SUM-101 Malaria Vaccine Candidate

Who this might be right for
Malaria Fever
European Vaccine Initiative
Early research (Phase 1)Study completedNCT00340431
What this trial is testing

Experimental Vaccine for Plasmodium Falciparum Malaria

Who this might be right for
Plasmodium Falciparum MalariaVaccines
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT00317473
What this trial is testing

Phase 1 Trial of a Malaria Vaccine in Young Kenyan Children

Who this might be right for
Plasmodium Falciparum Malaria
U.S. Army Medical Research and Development Command 135
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation